HealthcareAug 10, 2026

Guerbet

Company Profile Analysis

Book Demo Subscribe Now

Year Founded & Workforce

1925-12-31

2,800 Employees

Industry

Healthcare

Services

Guerbet Overview

Company Headquarters: Villepinte, France

Founded: 1926

Workforce: ~2,800

Company Working: Guerbet operates in the medical imaging field, offering a wide range of pharmaceutical products, medical devices, digital and artificial intelligence solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. Guerbet is continuously incorporating innovation in its products with research and development centers in France, Israel, and the US. The company operates in two reportable segments, diagnostic imaging, and intervention imaging.

Strategy

Guerbet focuses on developing innovative therapies through partnerships, joint ventures, and agreements. The company plans to enhance its strengths by emphasizing the expansion of its business by increasing its focus on embolization market trends in the coming years. Also, with the acquisition of Occlugel, the company aims to capture maximum market share in the embolization particle market in the near future.

Company Snapshot

$807.1M

Revenue

2,800

Employees

1925-12-31

Founded

Villepinte, France

Headquarters

SWOT Analysis

Strengths

Joint ventures with public and private organizations
Renowned customer base
Customer centric medical products
Mergers and acquisitions

Weaknesses

Limited product line
Limited focus on Oceanic countries

Opportunities

Expansion in untapped regions
Focus on expanding products offering

Threats

Legal risks
Volatile foreign exchange rates

Key Developments

Date	Approach	Development
June 2019	Product Approval	Guerbet’s product, Lipiodol Ultra Fluid, was approved in Switzerland and India for a new indication, chemoembolization (cTACE) of tumors in adults with known intermediate-stage hepatocellular carcinoma (HCC).
April 2018	Acquisition	Guerbet acquired a laboratory-stage technology developed by Occlugel, a French company specialized in the research and development of microspheres used in embolization

Product Offering

Guerbet
- Embolization Particle

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Guerbet as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Guerbet

Company Headquarters: Villepinte, France Founded: 1926 Workforce: ~2,800 Company Working: Guerbet operates in the medical imaging field, offering a wide range of pharmaceutical products, medical devices, digital and artificial intelligence solutions for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. Guerbet is continuously incorporating innovation in its products with research and development centers in France, Israel, and the US. The company operates in two reportable segments, diagnostic imaging, and intervention imaging.

Starting from

$4,950